Restructurings & Charges

INTEL CORP announced a restructuring with charges of $1.9 billion of restructuring charges affecting enterprise-wide (reduce our core Intel workforce by 15% by the end of fiscal 2025).

“The Company expects these headcount reduction initiatives will reduce our core Intel workforce by 15% by the end of fiscal 2025. As a result of initiating and deploying the 2025 Restructuring Plan, the Company expects to recognize $1.9 billion of restructuring charges related to these actions, of which the Company is recognizing $1.8 billion in the second quarter of 2025.”

ROCKET PHARMACEUTICALS, INC. announced a restructuring with charges of approximately $3.5 million (approximately 30%).

“The Company began notifying affected employees on July 23, 2025, and expects the RIF to be completed by August 8, 2025. The Company estimates that it will incur approximately $3.5 million in restructuring and restructuring-related charges in the second half of 2025 in connection with the Plan, consisting primarily of employee severance payments and other”

Cibus, Inc. announced a restructuring with charges of approximately $0.5 million (approximately 34 full-time employees).

“funded commercial opportunities. The Company expects that the reduction in workforce will be completed by December 31, 2025, and estimates that it will incur approximately $0.5 million of one-time charges for accrued vacation and severance payments in the third quarter of 2025 in connection with this reduction in workforce. The Company communicated the”

Adicet Bio, Inc. announced a restructuring with charges of approximately $2.3 million (approximately 30% of the Company’s current employee base).

“On July 22, 2025, the Board of Directors of Adicet Bio, Inc. (the Company or Adicet) approved a reduction in its workforce by approximately 30% of the Company’s current employee base in connection with its strategic pipeline prioritization, as disclosed under Item 8.01 of this Current Report on Form 8-K. This workforce reduction will be substantially completed by the end of the third quarter of 2025. As a result of these actions, the Company expects to incur personnel-related restructuring charges of approximately $2.3 million in connection with one-time employee termination cash expenditures, including severance and other benefits, which are expected to be substantially incurred in the third quarter of 2025.”

EnerSys announced a restructuring with charges of $15 million to $20 million affecting corporate and management positions (approximately 575 employees, or 11% of its non-production global workforce).

“11%, or approximately 575 employees, and is focused primarily on corporate and management positions. EnerSys estimates one-time charges related to the Plan to be in the range of $15 million to $20 million. These charges are cash expenditures associated with the Plan, primarily consisting of severance payments, notice period payments in applicable jurisdictions,”

Quanterix Corp announced a restructuring with charges of approximately $3.3 million affecting Akoya Biosciences, Inc. (newly acquired subsidiary) (certain executives of the Company's newly acquired subsidiary, Akoya Biosciences, Inc.).

“costs and streamlined operations and are expected to result in annualized cash savings of approximately $2.8 million. The Company expects to incur expenses of approximately $3.3 million, substantially all of which will be cash expenditures incurred in 2025 for severance required under Akoya’s Executive Severance Plan. The Company’s estimates are based on a”

Clearside Biomedical, Inc. announced a restructuring with charges of approximately $3.4 million for severance and other employee termination-related costs affecting the Company (all Clearside employees).

“On July 17, 2025, Clearside Biomedical, Inc. (the “ Company ”) announced that it is exploring strategic alternatives to enhance shareholder value, and that in connection with such process and in order to extend the Company’s resources, the Company is implementing a plan pursuant to which all Clearside employees will have their employment with the Company terminated and will transition into consulting roles with the Company. The reduction in force is expected to be completed during the third quarter of 2025. The Company estimates that it will incur charges of approximately $3.4 million for severance and other employee termination-related costs in the third quarter of 2025.”

TechTarget, Inc. announced a restructuring with charges of approximately $19.5 million to $45.0 million (up to approximately 10% of the Company's current global colleague base).

“of up to approximately 10% of the Company’s current global colleague base. As a result of the Plan, the Company estimates that it will incur aggregate charges of approximately $19.5 million to $45.0 million, of which approximately $9.5 million to $15.0 million, consists primarily of cash employee-related costs, including notice and severance, employee benefits and”

Sarepta Therapeutics, Inc. announced a restructuring with charges of between approximately $32 million and $37 million (approximately 36% of the Company's workforce).

“on July 14, 2025, the Board of Directors of the Company (the “Board”) approved a reduction in force, representing approximately 36% of the Company’s workforce. As a result of this reduction in force, the Company estimates that it will record a one-time charge in the third quarter of 2025 related to employee termination benefits, including severance, between approximately $32 million and $37 million”

Jamf Holding Corp. announced a restructuring with charges of approximately $11.0 million to $12.5 million affecting go-to-market and other functions (approximately 6.4%).

“Today, July 15, 2025, the Company announced the Plan, which is intended to reduce operating costs, improve operating margins, allow for strategic reinvestment, and continue advancing the Company’s ongoing commitment to profitable growth. The Plan is expected to impact approximately 6.4% of the Company’s full-time employees. The Company currently estimates that it will incur charges of approximately $11.0 million to $12.5 million in connection with the Plan”

Pacira BioSciences, Inc. announced a restructuring with charges of approximately $2.4 million to $2.8 million affecting Science Center Campus in San Diego, California (71 employees or approximately 8% of the Company’s total workforce).

“8% of the Company’s total workforce. The Company currently estimates that it will recognize pre-tax charges to its third quarter 2025 financial results of approximately $2.4 million to $2.8 million related to employee termination benefits, consisting of garden leave and severance, healthcare benefits, and, to a lesser extent, other one-time termination”

Jasper Therapeutics, Inc. announced a restructuring with charges of approximately $1.8 million - $2.2 million affecting the Company (approximately 50%).

“in chronic urticaria and is halting other clinical and preclinical programs along with the reduction in workforce. The Company estimates that it will incur approximately $1.8 million - $2.2 million of cash expenditures in connection with the corporate reorganization, which relate to severance pay, and are expected to be incurred through the quarter ending”

DOW INC. announced a restructuring with charges of $630 million to $790 million affecting global asset footprint.

“costs. The Company will record a charge in the second quarter of 2025 for costs associated with these activities. In total, these costs are expected to be in the range of $630 million to $790 million and will consist of asset write-downs and write-offs ranging from $330 million to $360 million (and described more fully in Item 2.06), costs associated with exit”

Century Therapeutics, Inc. announced a restructuring with charges of approximately $3.7 million (approximately 51%).

“On July 1, 2025, the Board of Directors (the “ Board ”) of Century Therapeutics, Inc. (the “ Company ”) approved a reduction in force as part of a broader effort to right size the organization to focus on programs with the highest potential for transformational value. The Company expects to implement a net reduction of its employee headcount by approximately 51% (the “ RIF ”). As part of the RIF, the Company estimates that it will incur charges of approximately $3.7 million for severance and other employee termination-related costs.”

Warner Music Group Corp. announced a restructuring with charges of approximately $200 million on a pre-tax basis or approximately $150 million on an after-tax basis.

“The Company expects to incur total non-recurring charges of approximately $200 million on a pre-tax basis or approximately $150 million on an after-tax basis.”

TerrAscend Corp. announced a restructuring affecting Michigan market (approximately 21% of the Company’s workforce of approximately 1,200).

“On June 27, 2025, the board of directors of TerrAscend Corp. (together with TerrAscend Corp.’s consolidated entities, the “Company”) approved certain restructuring actions related to the Company’s exit from the Michigan market, aimed at enabling the Company to focus on its operations in its more profitable markets.”

BNB PLUS CORP. announced a restructuring with charges of approximately $300 thousand in one-time charges affecting Applied DNA Clinical Labs (ADCL); company-wide workforce reduction (approximately 27% of headcount).

“Company’s former Chairman and Chief Executive Officer. The projected annual payroll savings is expected to be partially offset by approximately three hundred thousand dollars ($300,000) in one-time charges related to the workforce reduction and ceasing of operations at ADCL, primarily for separation benefits. The Company expects to incur the majority of”

Bumble Inc. announced a restructuring with charges of approximately $13 million to $18 million of non-recurring charges (approximately 240 roles, representing approximately 30% of the Company's employees).

“On June 23, 2025, the Board of Directors of Bumble Inc. (the “Company”) approved a reduction in the Company’s global workforce by approximately 240 roles, representing approximately 30% of the Company’s employees, as the Company realigns its operating structure to optimize execution on its strategic priorities. As a result, the Company expects to incur approximately $13 million to $18 million of non-recurring charges, consisting primarily of employee severance, benefits, and related charges, for impacted employees.”

OUTFRONT Media Inc. announced a restructuring with charges of approximately $18.6 million (approximately 120 employees, or 6% of the Company’s total number of employees).

“Company expects the reduction in force associated with the Plan to be completed by the end of the second quarter of 2025. The Company estimates that it will incur approximately $18.6 million in total restructuring charges in connection with the Plan, consisting of severance payments, employee benefits and related costs and professional fees. The Company expects to”

AMARIN CORP PLCUK announced a restructuring with charges of between approximately $30 million and $37 million affecting Europe operations.

“On June 24, 2025, as described in the Press Release, the Company announced a global restructuring, with the vast majority of estimated cost savings from reduced commercialization expense from the Company’s Europe operations. The Company expects these actions will reduce operating costs by approximately $70 million annually and is anticipated to be substantially completed by June 30, 2026. Amarin anticipates that it will incur between approximately $30 million and $37 million in charges related to the restructuring, substantially all of which are cash expenditures for one-time termination benefits and associated costs.”

DHI GROUP, INC. announced a restructuring with charges of approximately $4.2 million affecting Dice brand (approximately 25%).

“$14.0 million to $16.0 million. The savings will begin to be realized immediately subsequent to the restructuring. The Company estimates that it will incur approximately $4.2 million in cash charges related to employee severance and benefits. Substantially all charges are expected to be recognized in the second quarter of 2025 while the related cash payments”

CYPHERPUNK TECHNOLOGIES INC. announced a restructuring with charges of approximately $3.2 million affecting the Company's research and development activities, including the Company's sirexatamab and FL-501 development programs (approximately 75% of the Company's current workforce).

“Due to current market conditions and the financial position of Leap Therapeutics, Inc. (the “Company”), the Company’s Board of Directors has approved a series of measures to conserve cash and reduce operating costs, including (i) the completion of the DeFianCe clinical trial and the wind-down of the Company’s research and development activities, including the Company’s sirexatamab and FL-501 development programs, and (ii) a reduction in force that will impact approximately 75% of the Company’s current workforce (the “Reduction In Force”) to be implemented in two phases (a) first, on or about June 30, 2025 that will impact the Company’s Chief Operating Officer, and (b) second, on or about July 31, 2025 that will impact the Chief Medical Officer of the Company. The Company estimates that it will incur approximately $3.2 million in costs primarily related to severance payments and related expenses in connection with the Reduction In Force.”

MAMMOTH ENERGY SERVICES, INC. announced a impairment with charges of ranging between $7.7 million and $9.2 million affecting hydraulic fracturing business.

“As a result, the Company expects to recognize impairment expense during the second quarter of 2025 ranging between $7.7 million and $9.2 million.”

JABIL INC announced a restructuring with charges of approximately $200 million.

“The Company expects the total amount of pre-tax restructuring and other related costs to be approximately $200 million, including the following estimated items: • $60 million to $70 million of employee severance and benefit costs; • $65 million to $70 million of asset write-off costs; and • $55 million to $65 million of contract termination costs and other related costs.”

PROTHENA CORP PUBLIC LTD CO announced a restructuring with charges of approximately $16 to $20 million (approximate 63% reduction in its workforce).

“periods will be extended, pursuant to the terms of the option award agreements under which those stock options were granted. The Company expects to recognize approximately $16 to $20 million in total for severance and related benefits for employees laid off under the reduction in workforce and non-cash share-based compensation expense related to the”

WESTLAKE CORP announced a restructuring with charges of approximately EUR 190 million affecting Pernis facility (approximately 230 employees).

“On June 17, 2025, the Company notified the affected employees at the Pernis facility of the Company's plan. The anticipated closure of the entire Pernis facility would take place after the conclusion of the consultations with local works councils and unions. In addition to the previous charges related to the July 2024 mothballing, the Company expects it would incur total pre-tax costs of approximately EUR 190 million related to the closure of the Pernis facility.”

VINEBROOK HOMES TRUST, INC. announced a impairment with charges of $5.7 million.

“on June 10, 2025, in connection with the Externalization described above, the Company estimates it will recognize $5.7 million in non-cash impairment of finite-lived intangible assets related to capitalized software development costs”

VINEBROOK HOMES TRUST, INC. announced a restructuring with charges of $2.8 million to $3.1 million (approximately 500 employees, representing 100% of our full-time employees).

“in force by the end of 2025. The Company estimates it will recognize aggregate pre-tax cash expenditures related to severance and one-time termination benefits ranging from $2.8 million to $3.1 million, the majority of which is expected to be paid in the fourth quarter of 2025. The implementation of the headcount reductions, including cash payments, is expected”

ADC Therapeutics SA announced a restructuring with charges of approximately $6 million to $7 million affecting U.K. research and development facility (approximately 30%).

“On June 11, 2025, the Board of Directors of the Company approved a strategic reprioritization and restructuring plan (the “Restructuring”) to focus resources on ZYNLONTA® (loncastuximab tesirine-lpyl) expansion opportunities and the advancement of its preclinical exatecan-based ADC targeting prostate-specific membrane antigen (PSMA). The Company will discontinue early development efforts for the remaining preclinical programs in solid tumors. In connection with the Restructuring, the Company plans to shut down its U.K. research and development facility and reduce its global workforce across functions by approximately 30%, which is expected to be substantially completed by September 30, 2025. The Company estimates that it will incur one-time pre-tax restructuring charges of approximately $6 million to $7 million for employee severance, benefits and related termination costs, the majority of which the Company expects to be recognized in the second quarter of 2025.”

RECURSION PHARMACEUTICALS, INC. announced a restructuring with charges of approximately $11 million (approximately 20%).

“into the fourth quarter of 2027. These changes are expected to result in a workforce reduction of approximately 20%. The Company estimates that it will incur approximately $11 million in charges in connection with the workforce reduction, consisting of severance payments, employee benefits, and related costs, substantially all of which the Company expects to”

NOVANTA INC announced a restructuring with charges of approximately $20 million to $25 million.

“strategies in areas anticipated to have a minimal long-term impact on the Company's overall business performance. The Company estimates that it will incur approximately $20 million to $25 million in pre-tax charges in connection with the 2025 Restructuring Plan, consisting of employee-related costs, third-party manufacturing moving costs, contract”

ZoomInfo Technologies Inc. announced a restructuring with charges of $4 million to $5 million (approximately 6%).

“The Plan includes a reduction of current employees by approximately 6% in the second quarter of 2025. The Company estimates the aggregate costs associated with the Plan to be approximately $4 million to $5 million, primarily consisting of severance payments, employee benefits, and related costs.”

LyondellBasell Industries N.V. announced a impairment affecting Olefins & Polyolefins-Europe, Asia, International (O&P-EAI) segment, including facilities at Carrington (UK), Tarragona (Spain), Münchsmünster (Germany), and Berre (France).

“All other long-lived assets of the Target Group have been fully impaired as of June 2025.”

LyondellBasell Industries N.V. announced a restructuring with charges of approximately $700 million to $900 million affecting Olefins & Polyolefins-Europe, Asia, International (O&P-EAI) segment, including facilities at Carrington (UK), Tarragona (Spain), Münchsmünster (Germany), and Berre (France).

“LYB expects to recognize a loss on sale estimated to be approximately $700 million to $900 million.”

Sunnova Energy International Inc. announced a restructuring (approximately 718 employees (approximately 55% of the Company's workforce)).

“On May 29, 2025, the Special Committee of the Board of Directors of the Company approved a reduction in force (the “Reduction in Force”), effective May 30, 2025, of approximately 718 employees (approximately 55% of the Company’s workforce)”

GOODYEAR TIRE & RUBBER CO /OH/ announced a restructuring with charges of between $100 million and $110 million affecting Europe, Middle East and Africa (“EMEA”) business unit (approximately 900 job reductions).

“On June 2, 2025, The Goodyear Tire & Rubber Company (the “Company”) approved a proposed plan to close our manufacturing facility in Kariega, South Africa in the Europe, Middle East and Africa (“EMEA”) business unit. The proposed plan includes approximately 900 job reductions, including associates and contracted positions, and is expected to be substantially complete by the end of 2025. The total charges associated with this action are expected to be between $100 million and $110 million, of which $45 million to $55 million are expected to be cash charges primarily for associate-related and other exit costs and the remaining costs are expected to be non-cash charges primarily for accelerated depreciation and other asset-related charges.”

Transocean Ltd. announced a impairment with charges of between $1.1 billion and $1.2 billion affecting GSF Development Driller I, Discoverer Luanda, Development Driller III, Discoverer Inspiration.

“the Company concluded that it expects its second quarter 2025 results to include an estimated non-cash charge ranging between $1.1 billion and $1.2 billion associated with the impairment of these rigs and related assets.”

Simulations Plus, Inc. announced a restructuring with charges of approximately $0.7 million (approximately 23 employees).

“The reduction in workforce will decrease overall headcount by approximately 23 employees, which represents approximately 10% of full-time employees as of the Effective Date. The Company estimates that it will incur approximately $0.7 million in charges in connection with the restructuring, consisting of severance payments, employee benefits, and related costs”

Keros Therapeutics, Inc. announced a restructuring with charges of approximately $3.2 million (approximately 45%).

“These plans were communicated to affected employees on May 29, 2025. The Company expects to incur one-time cash charges associated with the Reorganization of approximately $3.2 million related to employee severance payments and related costs, which are expected to be expensed in the second quarter of 2025. In addition, the Company has committed to pay one-time”

iTeos Therapeutics, Inc. announced a restructuring with charges of $21.8 million to $24.7 million affecting Company-wide (clinical and operational activities).

“The Company expects to incur charges in connection with the wind down consisting of (i) severance and other termination costs related to employees who would be terminated of approximately $21.8 million to $24.7 million”

Princeton Bancorp, Inc. announced a impairment with charges of $9.9 million affecting two commercial real estate loans.

“Based on the bids received for such loans, on May 28, 2025, the Registrant’s Board of Directors, Chief Executive Officer and Chief Financial Officer concluded that a material charge for impairment to such loans is required under generally accepted accounting principles applicable to the Registrant. The amount of the net impairment charge is estimated to be $9.9 million”

EASTERN CO announced a restructuring with charges of approximately $1.0 million.

“In connection with the reduction in force, the Company estimates that it will incur aggregate charges of approximately $1.0 million, which will be recorded primarily in the 2 nd quarter of 2025, related to severance payments and other employee-related costs, and contract termination costs.”

nCino, Inc. announced a restructuring with charges of approximately $7.5 to $9.0 million, inclusive of $1.0 million of estimated non-cash charges (approximately seven percent (7%)).

“substantially completed by the end of the second quarter of the Company’s fiscal 2026. The Company expects to incur charges in the second quarter of fiscal 2026 of approximately $7.5 to $9.0 million, inclusive of $1.0 million of estimated non-cash charges, primarily for asset disposals in connection with the Plan. Cash payments consisting of severance and”

GENERAL MILLS INC announced a restructuring with charges of approximately $130 million affecting global business processes.

“On May 20, 2025, General Mills, Inc. (the “Company”) approved a multi-year global transformation initiative intended to drive increased productivity by enhancing end-to-end business processes, enabled by targeted organizational actions. The Company anticipates that the series of actions related to the transformation initiative will be substantially completed by the end of fiscal 2028 and will result in total charges of approximately $130 million, of which approximately $120 million will be cash.”

Boundless Bio, Inc. announced a restructuring with charges of approximately $1.2 million (approximately one-third of the Company’s workforce).

“On May 23, 2025, Boundless Bio, Inc. (the Company), in connection with the portfolio prioritization described below, announced a workforce reduction of approximately one-third of the Company’s workforce. The Company expects to incur one-time costs of approximately $1.2 million in connection with the workforce reduction primarily related to one-time termination benefits (some of which are contractual), including severance and healthcare related benefits.”

Blink Charging Co. announced a restructuring with charges of between $1 million and $1.5 million (approximately 20%).

“The Company estimates it will incur between $1 million and $1.5 million of related costs, consisting of cash severance, other severance benefits, and other related restructuring costs.”

SIGNET JEWELERS LTD announced a restructuring with charges of $30 million to $45 million affecting North America reportable segment.

“time the Plan was announced on March 19, 2025, the costs expected to be incurred under the Plan were still being evaluated. Currently, the Company estimates that approximately $30 million to $45 million of costs will be incurred, including $10 million to $15 million of estimated non-cash charges, primarily for asset disposals and impairment charges. The Company”

Aterian, Inc. announced a restructuring with charges of approximately $2.3 million (approximately 20 employees).

“On May 14, 2025, the Company announced a fixed cost reduction plan, which includes a workforce reduction affecting approximately 20 employees. The Company expects to substantially complete this reduction by the end of the third quarter of 2025. In connection with this plan, the Company anticipates recognizing restructuring charges of approximately $2.3 million, primarily related to severance, during the second quarter of 2025.”

MAGNACHIP SEMICONDUCTOR Corp announced a restructuring with charges of approximately $12 to $15 million affecting Magnachip Mixed-Signal, Ltd., the Company’s wholly owned subsidiary that operated the Company’s discontinued Display business.

“The total estimated cash cost of the Liquidation is approximately $12 to $15 million, which is expected to be offset by the cash inflow that the Company will generate as described above.”

CHEGG, INC announced a restructuring with charges of approximately $34 million to $38 million (248 employees, or approximately 22% of our current workforce).

“with ongoing industry challenges that are negatively impacting our business, including a decline in our traffic. We estimate that we will incur charges of approximately $34 million to $38 million in connection with these actions, of which $31 million to $35 million is expected to result in future cash expenditures, primarily consisting of expenditures for”